EUVIMEDEUVIMED entdecken
Crossref

Tunable 18 F‐Labeling of Erlotinib‐Based Small Molecule Nanodrugs for Rapid PET Imaging and Targeted Therapy

Jiafeng Li, Yiru Jiang iD, Jiwei Cui iD, Yan Wu iD, Sunli Wan, Zhiheng Meng, Wangxi Hai iD, Peiyong Li iD, Xin Jin iD, Xinyuan Zhu iD

Small · 2026-11 · 22 (63)

DOI: 10.1002/smll.76439 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 02.11.2026. Verfasst von Jiafeng Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department State Key Laboratory of Synergistic Chem-Bio Synthesis, School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shang…. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Fluorine Radioisotopes, Erlotinib Hydrochloride, Nanoparticles. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Shanghai Municipal Science and Technology Major Project and Advanced Materials-National Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Small molecule nanodrugs (SMNs) offer unique advantages for cancer therapy, yet accurately tracking their in vivo fate without perturbing their native assembly remains challenging. Here, we report a spacer engineering strategy that enables efficient 1 8 F‐labeling while preserving SMNs self‐assembly. Erlotinib‐based amphiphilic derivatives containing oligoethylene glycol (OEG) spacers of tunable length were designed to simultaneously regulate steric hindrance for aliphatic S N 2 radiofluorination and the amphiphilic balance required for nanoparticle formation. Spacer elongation reduced steric hindrance at the labeling site and thereby improved radiochemical yields, while also enabling precise control over nanoparticle size. The optimized radiolabeled formulation, [ 18 F]E3F NPs , exhibited prolonged blood circulation and rapid tumor accumulation, enabling high‐contrast PET imaging of PANC‐1 xenografts as early as 15 min after injection. In addition, the corresponding nonradioactive formulation, E3F NPs , showed significantly improved antitumor efficacy compared with nonassembled E3F through reduced EGFR phosphorylation and increased tumor cell apoptosis. This work provides an initial evaluation that spacer engineering can coordinate radiolabeling and self‐assembly while enabling PET tracking of SMNs, supporting the development of image‐guided cancer theranostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographyFluorine RadioisotopesErlotinib HydrochlorideNanoparticlesAnimalsHumansCell Line, TumorMiceErbB ReceptorsMice, Nude

Stichwörter der Autor:innen

rapid PET imagingsmall molecule nanodrugstunable 18F‐labelingtunable self‐assembly

Substanzen

Fluorine RadioisotopesErlotinib HydrochlorideFluorine-18ErbB Receptors

Autor:innen und Institutionen

  • Department State Key Laboratory of Synergistic Chem-Bio Synthesis, School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
  • Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
  • State Key Laboratory of Brain Function and Disorders, Department of Radiology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
  • Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, People's Republic of China.
  • Department of Radiology, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.

ORCID-Profile: Yiru Jiang, Jiwei Cui, Yan Wu, Wangxi Hai, Peiyong Li, Xin Jin, Xinyuan Zhu

Förderung

  • Shanghai Municipal Science and Technology Major Project and Advanced Materials-National Science and Technology Major Project

Zitieren

APA

Li, J., Jiang, Y., Cui, J., Wu, Y., Wan, S., Meng, Z., Hai, W., Li, P., Jin, X., & Zhu, X. (2026). Tunable 18 F‐Labeling of Erlotinib‐Based Small Molecule Nanodrugs for Rapid PET Imaging and Targeted Therapy. Small, 22(63). https://doi.org/10.1002/smll.76439

Vancouver

Li J, Jiang Y, Cui J, Wu Y, Wan S, Meng Z, et al. Tunable 18 F‐Labeling of Erlotinib‐Based Small Molecule Nanodrugs for Rapid PET Imaging and Targeted Therapy. Small. 2026;22(63). doi:10.1002/smll.76439

BibTeX
@article{Li2026,
  author = {Li, Jiafeng and Jiang, Yiru and Cui, Jiwei and Wu, Yan and Wan, Sunli and Meng, Zhiheng and Hai, Wangxi and Li, Peiyong and Jin, Xin and Zhu, Xinyuan},
  title = {Tunable 18 F‐Labeling of Erlotinib‐Based Small Molecule Nanodrugs for Rapid PET Imaging and Targeted Therapy},
  journal = {Small},
  year = {2026},
  volume = {22},
  number = {63},
  doi = {10.1002/smll.76439}
}
Kostenlos starten →